|
MechanismCXCR4 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCXCR4 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with InPheno AG
0 Patents (Medical) associated with InPheno AG
100 Deals associated with InPheno AG
100 Translational Medicine associated with InPheno AG